Benzinga · Aug 25, 2026
Nvidia To Rally More Than 8%? Here Are 10 Top Analyst Forecasts For Tuesday
Top Wall Street analysts upgraded and raised price targets for FLNC, DT, NVDA, SNOW, TFX, COIN, and EXPE. See how other analysts view these stocks.
NYSE · TFX
Teleflex Incorporated
Healthcare · Medical - Instruments & Supplies
$139.67
Up+$1.96 (+1.42%)
Updated Aug 31, 2026, 11:37 AM
SID Score
6.0/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 5.63B
- P/E ratio
- -17.18
- Dividend yield
- 0.97%
- 52-week range
- $100.18 – $145.00
- Volume
- 429.36K
- Avg. volume
- 634.31K
Price performance
TFX price history
1M range · 20 trading sessions · Daily adjusted prices
TFX closed at $139.67 after 20 trading sessions, down 0.02% for the selected period.
- Last close
- $139.67
- Period change
- -0.02%
- Period low
- $131.92
- Period high
- $140.18
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 28, 2026 | $137.35 | $140.57 | $137.35 | $139.67 | 429.36K |
| Aug 27, 2026 | $136.55 | $138.51 | $136.55 | $137.71 | 370.58K |
| Aug 26, 2026 | $139.14 | $140.17 | $137.955 | $138.74 | 533.77K |
| Aug 25, 2026 | $138.01 | $140.57 | $136.32 | $140.18 | 382.41K |
| Aug 24, 2026 | $138.87 | $140.275 | $137.71 | $138.31 | 645.09K |
| Aug 21, 2026 | $133.31 | $139.21 | $133.31 | $138.83 | 641.97K |
| Aug 20, 2026 | $135.12 | $137.28 | $134.88 | $134.96 | 297K |
| Aug 19, 2026 | $132.63 | $136.80 | $132.63 | $135.86 | 459.65K |
| Aug 18, 2026 | $133.50 | $136.04 | $130.89 | $131.92 | 872.41K |
| Aug 17, 2026 | $135.56 | $135.98 | $132.85 | $133.07 | 687.58K |
| Aug 14, 2026 | $137.20 | $138.005 | $135.695 | $137.17 | 586.07K |
| Aug 13, 2026 | $135.915 | $137.54 | $135.17 | $137.37 | 963.89K |
| Aug 12, 2026 | $132.82 | $136.32 | $132.16 | $136.32 | 515.66K |
| Aug 11, 2026 | $135.14 | $136.398 | $132.85 | $133.54 | 614.26K |
| Aug 10, 2026 | $135.03 | $137.08 | $132.14 | $133.00 | 586.09K |
| Aug 7, 2026 | $138.26 | $139.72 | $133.63 | $134.98 | 752.28K |
| Aug 6, 2026 | $141.16 | $145.00 | $130.0331 | $138.89 | 1.33M |
| Aug 5, 2026 | $140.16 | $141.315 | $136.78 | $136.78 | 645.25K |
| Aug 4, 2026 | $139.20 | $141.245 | $138.315 | $140.12 | 605.11K |
| Aug 3, 2026 | $138.25 | $144.19 | $138.25 | $139.70 | 1.01M |
Latest TFX news
The latest Smart Investors Daily articles mentioning TFX.
Stock researchCompany · Overview
TFX research
Overview
Company profile and research snapshot.
Company profile
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2024 sales), interventional (19%), anesthesia (13%), surgical (15%), interventional urology (11%), original-equipment manufacturing (11%), and other (7%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $129.50
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 25, 2026 | Needham | Buy | — |
| Aug 11, 2026 | UBS | Neutral | — |
| Aug 10, 2026 | Truist Securities | Hold | — |
| Aug 7, 2026 | Piper Sandler | Overweight | — |
| Jul 31, 2026 | Needham | Buy | — |
News briefing
No generated briefing is available yet.
Benzinga · Aug 25, 2026
Needham Maintains Buy on Teleflex, Raises Price Target to $170
Needham analyst Mike Matson maintains Teleflex (NYSE:TFX) with a Buy and raises the price target from $159 to $170.
SeekingAlpha · Aug 23, 2026
Teleflex: Strong Company Undergoing Messy Transition, Hold
Teleflex Q2 beat, but BIOTRONIK Vascular Intervention integration risks loom. Click for more on TFX stock.
SeekingAlpha · Aug 22, 2026
Teleflex: Portfolio Surgery Creates A Better Medtech Compounder
Teleflex's Vascular and Surgical segments are generating high-single-digit growth. Find out why TFX stock is a Buy.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
